Pinion Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Buy
+4,158
New +$239K 0.05% 189
2021
Q3
– Sell
-4,480
Closed -$299K – 148
2021
Q2
$299K Sell
4,480
-474
-10% -$30.9K 0.24% 125
2021
Q1
$313K Buy
4,954
+335
+7% +$20.8K 0.29% 116
2020
Q4
$287K Sell
4,619
-823
-15% -$50.6K 0.3% 112
2020
Q3
$320K Hold
5,442
– – 0.48% 83
2020
Q2
$320K Buy
+5,442
New +$326K 0.48% 83

Other funds holding BMY

Pinion Investment Advisors's BMY Position: Q2 2026 in Review

Pinion Investment Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 4,158 shares worth $240K. The stake represents 0.05% of the portfolio and ranks #189 among its holdings. This is a return to the name: Pinion Investment Advisors previously reported a position in BMY as recently as Q2 2021.

Pinion Investment Advisors first reported a position in BMY in Q2 2020 and has held it in 6 quarters since. The position peaked at $320K in Q3 2020. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Pinion Investment Advisors held 4,158 shares of Bristol-Myers Squibb worth $240K as of Q2 2026.
  • Bristol-Myers Squibb was a new Pinion Investment Advisors position in Q2 2026.
  • Bristol-Myers Squibb made up 0.05% of Pinion Investment Advisors's portfolio in Q2 2026, its #189 holding.
  • Pinion Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 6 quarters since.
  • Pinion Investment Advisors's Bristol-Myers Squibb position peaked at $320K in Q3 2020.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Pinion Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.